Ерлотиниб С Сандоз

Erlotinib Sandoz is an oral medication prescribed for certain types of cancer. It belongs to the class of tyrosine kinase inhibitors. This product is manufactured by Sandoz Pharmaceuticals D.D. and is available in the EU market.

Erlotinib is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by inhibiting specific enzymes that promote cancer cell growth. Patients often ask, 'what is erlotinib used for' to understand its role in cancer therapy. This medication may also be considered in broader oncology contexts.

Erlotinib is taken orally and may help slow the progression of cancer cells. Users often report feeling more stable during treatment. It is important to note that individual responses can vary widely. Always follow healthcare provider guidance when taking this medication.

Keep erlotinib in a cool, dry place away from direct sunlight. Store it securely, out of reach of children and pets. If you are pregnant, breastfeeding, or planning a pregnancy, consult your doctor before use. Regular check-ups are recommended to monitor its effects.

Erlotinib may interact with certain medications, including blood thinners and some antibiotics. Avoid consuming grapefruit or grapefruit juice while taking this drug. Alcohol use should be discussed with a healthcare provider. Always inform your doctor about all medications you are currently taking.